Skip to main content

Table 1 Ongoing clinical trials in C9-ALS/FTD patients

From: The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD

Back to article page

Molecular Neurodegeneration

ISSN: 1750-1326